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Efﬁe W. Petersdorf, MD, has been
installed as President of the American
Society for Blood and Marrow Trans-
plantation. She is a Member of the Di-
vision of Clinical Research at the Fred
Hutchinson Cancer Research Center; a
Professor of Medicine at the University
of Washington School of Medicine,
Seattle and an Attending Physician of
clinical bone marrow transplant ser-
vices at the Fred Hutchinson Cancer
Research Center and Seattle Cancer Care
Alliance.
Ginna Laport, MD is a Professor of
Medicine in the Division of Blood and
Marrow at the Stanford University
Medical Center. She is Director of Clin-
ical Research and the Biostatistical Core
in her Division and previously held
faculty positions in the Division of He-
matology/Oncology at the University of
Pennsylvania and at the University of
Chicago. Dr. Laport is the newly elected
and installed Vice President, to become
President in 2017.
Corey Cutler, MD, MPH, FRCP(C) is
the newly elected and installed Trea-
surer. He is an Associate Professor of
Medicine at Harvard Medical School,
and is a Senior Physician in the Division
of Hematologic Oncology, Department
of Medical Oncology at the Dana-Farber
Cancer Institute and Brigham and
Women’s Hospital, Boston, MA.
The installation of new ofﬁcers and
directors occurred at the Society’s
Annual Business Meeting, during the
2015 BMT Tandem Meetings, on Feb.
13th in San Diego, California. The elec-
tion was by ballot among members of
the Society in December and January.
Newly elected and installed directors
are:
Director, Community/Clinical Prac-
tice: Patrick J. Stiff, MD of Loyola
Medical Center in Chicago, ILhttp://dx.doi.org/10.1016/j.bbmt.2015.01.007
1083-8791Director, Laboratory Science: Colleen
Delaney, MD of Fred Hutchinson
Cancer ResearchCenter in Seattle,WA
Director, At Large: Navneet S. Maj-
hail, MD, MS of Cleveland Clinic in
Cleveland, OH
All took ofﬁce at the close of the 2015
BMT Tandem Meetings.
Christopher N. Bredeson, MD, MSc,
FRCPC was elevated to President-Elect
and will assume the Presidency in
2016. He is professor of medicine in the
Division of Hematology, University of
Ottawa and Head, Malignant Hematol-
ogy and BMT at the Ottawa Hospital.
Three New Investigators Win BBMT
Editorial Awards
Three medical scientists are the
recipients of editorial awards for new
investigators for their articles published
in 2014 in Biology of Blood and Marrow
Transplantation. Selectionof thewinning
articles was by the BBMT Editorial Board
and the ASBMT Publications Committee.
The Ernest McCulloch & James Till and
George Santos Awards are supported
jointly by grants from STEMCELL Tech-
nologies Inc., and STEMSOFT Software Inc.
The ASBMT/BBMT Karl Blume Award
was established last year by ASBMT in
memory of Dr. Karl Blume.
Jessica C. Shand, MD (University of
Rochester Medical Center) is the recip-
ient of the Ernest McCulloch & James Till
Award for best basic science article by a
new investigator. Her article was “Minor
Antigen Distribution Predicts Site-Speciﬁc
Graft-versus-Tumor Activity of Adoptively
Transferred, Minor Antigen-Speciﬁc CD8 T
Cells.”
Alex F. Herrera, MD (Dana-Farber
Cancer Institute) is the recipient of the
George Santos Award for best clinical
science article by a new investigator. His
article was “A Phase II Study of Bortezo-
mib Plus Prednisone for Initial Therapy of
Chronic Graft-versus-Host Disease.”Marie Bleakley, MD, PhD (Fred
Hutchinson Cancer Research Center) is
recipient of the Karl Blume Award for
best clinical science article by a new
investigator. Her article was “Engineer-
ing Human Peripheral Blood Stem Cell
Grafts that are Depleted of Naïve T Cells
and Retain Functional Pathogen-Speciﬁc
Memory T Cells.”
The awards were presented by
ASBMT’s President, Sergio A. Giralt, MD,
during the 2015 BMT Tandem Meetings
in San Diego, California.
Six Abstracts were Chosen as Best For
the 2015 BMT Tandem Meetings
A total of 613 abstracts from 28
countries were submitted for the 2015
BMT Tandem Meetings.
Six of the abstracts were selected for
awards by the Abstract Review
Committees.
Recipients of the ASBMT Best Ab-
stract Awards for Basic Science Research
were:
Saad S. Kenderian, MD e “CD33
Directed Chimeric Antigen Receptor T-Cell
Therapy as a Novel Preparative Regimen
Prior to Allogeneic Stem Cell Trans-
plantation in Acute Myeloid Leukemia”
Sonoko Shimoji, MD e “Graft-
Versus-Host Disease Targets Granulosa
Cell of Ovarian Follicle and Causes Infer-
tility after Allogeneic Hematopoietic Stem
Cell Transplantation”
Yusuke Shono, MD, PhD e “Treat-
ment with Antibiotics Containing Activity
against Obligate Anaerobes Worsens
GVHD Survival in Mice and Humans after
Allogeneic BMT”
Recipients of the CIBMTR Best Ab-
stract Awards for Clinical Research
were:
Craig H. Moskowitz, MD e “The
AETHERA Trial: Results of a Randomized
Double-Blind, Placebo-Controlled Phase
3 Study of Brentuximab Vedotin in the
Treatment of Patients at Risk of
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Stem Cell Transplant for Hodgkin
Lymphoma”
Sandeep Soni, MBBS, MD e “Early
Results of a Phase I/II Study of Gene
Therapy for ß - Thalassemia Major viaTransplantation of Autologous Hemato-
poietic Stem Cells Transduced Ex-Vivo
with a Lentiviral ß AT87Q-Globin
Vector”
Heather J. Symons, MD, MHS e
“Haploidentical BMT Using FullyMyeloablative Conditioning, T-Cell
Replete Bone Marrow Grafts, and Post-
Transplant Cyclophosphamide has
Limited Toxicity and Promising Efﬁcacy in
Largest Reported Experience with High-
Risk Hematologic Malignancies”
